Related Experiment Video
Updated: Jul 27, 2026
A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Economic impact of automated primary screening for cervical cancer
Objective:
To construct a markovian model to project the marginal cost of the AutoPap System as compared to manual cervical cytologic screening.
Study Design:
Data from a clinical trial and published literature were entered into a seven-state markovian decision-analytic model to estimate the marginal cost per year of life saved that could be attributed to changes in primary screening technology.
Results:
Annual screening with AutoPap produced a meaningful increase in life expectancy of 32.1 days relative to manual screening at a marginal savings of $628 per person (or a marginal savings of $7,144 per life-year saved). Less frequent screening yielded lower positive savings.
Conclusion:
Automated screening for cervical cancer has the potential to significantly improve health care outcomes and reduce cost.
